Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center

Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Shutaro, Takamatsu, Akane, Akazawa, Manabu, Goto, Takao, Miwa, Toshiki, Terayama, Yoshiyasu, Honda, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726539/
https://www.ncbi.nlm.nih.gov/pubmed/36483370
http://dx.doi.org/10.1017/ash.2022.42
_version_ 1784844810940579840
author Murakami, Shutaro
Takamatsu, Akane
Akazawa, Manabu
Goto, Takao
Miwa, Toshiki
Terayama, Yoshiyasu
Honda, Hitoshi
author_facet Murakami, Shutaro
Takamatsu, Akane
Akazawa, Manabu
Goto, Takao
Miwa, Toshiki
Terayama, Yoshiyasu
Honda, Hitoshi
author_sort Murakami, Shutaro
collection PubMed
description Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased.
format Online
Article
Text
id pubmed-9726539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-97265392022-12-07 Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center Murakami, Shutaro Takamatsu, Akane Akazawa, Manabu Goto, Takao Miwa, Toshiki Terayama, Yoshiyasu Honda, Hitoshi Antimicrob Steward Healthc Epidemiol Concise Communication Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased. Cambridge University Press 2022-04-05 /pmc/articles/PMC9726539/ /pubmed/36483370 http://dx.doi.org/10.1017/ash.2022.42 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided that no alterations are made and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use and/or adaptation of the article.
spellingShingle Concise Communication
Murakami, Shutaro
Takamatsu, Akane
Akazawa, Manabu
Goto, Takao
Miwa, Toshiki
Terayama, Yoshiyasu
Honda, Hitoshi
Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title_full Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title_fullStr Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title_full_unstemmed Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title_short Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center
title_sort changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (covid-19) pandemic: an experience at a tertiary-care center
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726539/
https://www.ncbi.nlm.nih.gov/pubmed/36483370
http://dx.doi.org/10.1017/ash.2022.42
work_keys_str_mv AT murakamishutaro changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT takamatsuakane changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT akazawamanabu changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT gototakao changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT miwatoshiki changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT terayamayoshiyasu changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter
AT hondahitoshi changesinintravenousandoralantimicrobialprescriptionsduringthecoronavirusdisease2019covid19pandemicanexperienceatatertiarycarecenter

Ejemplares similares